Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose

Autor: Sholukh AM, Siddappa NB, Shanmuganathan V, Lakhashe SK, Rasmussen RA, Watkins JD, Vyas HK, Mukhtar MM, Hemashettar G, Thorat S, Yoon JK, Villinger F, Novembre FJ, Landucci G, Forthal DN, Ratcliffe S, Robert-Guroff M, Polonis V, Montefiori DC, Ertl HC, Ruprecht RM

Publikováno v: Retrovirology, Vol 9, Iss Suppl 2, p P41 (2012)

Externí odkaz: https://doaj.org/article/43f004c324484450af022db908636fad

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.

Autor: Lakhashe SK; Texas Biomedical Research Institute, San Antonio, TX, United States., Amacker M; Department of Pulmonary Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.; Mymetics SA, Epalinges, Switzerland., Hariraju D; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States., Vyas HK; Texas Biomedical Research Institute, San Antonio, TX, United States., Morrison KS; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States., Weiner JA; Thayer School of Engineering, Dartmouth College, Hanover, NH, United States., Ackerman ME; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States.; Thayer School of Engineering, Dartmouth College, Hanover, NH, United States., Roy V; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States., Alter G; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, United States., Ferrari G; Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Montefiori DC; Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States., Tomaras GD; Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States., Sawant S; Department of Surgery, Duke University, Durham, NC, United States., Yates NL; Department of Surgery, Duke University, Durham, NC, United States., Gast C; Texas Biomedical Research Institute, San Antonio, TX, United States.; Department of Pulmonary Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.; Mymetics SA, Epalinges, Switzerland.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States.; Thayer School of Engineering, Dartmouth College, Hanover, NH, United States.; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.; Massachusetts Consortium on Pathogen Readiness, Boston, MA, United States.; Department of Surgery, Duke University, Durham, NC, United States.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States.; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, United States.; Department of Immunology, Duke University, Durham, NC, United States.; Fred Hutchinson Cancer Research Center, Seattle, WA, United States., Fleury S; Mymetics SA, Epalinges, Switzerland., Ruprecht RM; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Feb 22; Vol. 13, pp. 788619. Date of Electronic Publication: 2022 Feb 22 (Print Publication: 2022).

Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges.

Autor: Gong S; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States., Lakhashe SK; Texas Biomedical Research Institute, San Antonio, TX, United States., Hariraju D; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States., Scinto H; Texas Biomedical Research Institute, San Antonio, TX, United States.; Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, United States., Lanzavecchia A; Institute for Research in Biomedicine, Bellinzona, Switzerland.; Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Cameroni E; Institute for Research in Biomedicine, Bellinzona, Switzerland.; Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Corti D; Institute for Research in Biomedicine, Bellinzona, Switzerland.; Humabs BioMed, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Ratcliffe SJ; University of Pennsylvania, Philadelphia, PA, United States., Rogers KA; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States., Xiao P; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States., Fontenot J; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States., Villinger F; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States., Ruprecht RM; Texas Biomedical Research Institute, San Antonio, TX, United States.; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA, United States.; Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, San Antonio, TX, United States.; Department of Biology, University of Louisiana at Lafayette, Lafayette, LA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Aug 03; Vol. 12, pp. 705592. Date of Electronic Publication: 2021 Aug 03 (Print Publication: 2021).

Lymphocytes upregulate CD36 in adipose tissue and liver.

Autor: Couturier J; a Division of Infectious Diseases, Department of Internal Medicine , The University of Texas Health Science Center at Houston , Houston , TX , USA., Nuotio-Antar AM; b US Department of Agriculture/Agricultural Research Center, Children's Nutrition Research Center, Department of Pediatrics , Baylor College of Medicine , Houston , TX , USA., Agarwal N; c Division of Diabetes, Endocrinology and Metabolism, Department of Medicine , Baylor College of Medicine , Houston , TX , USA., Wilkerson GK; d Department of Comparative Medicine , The University of Texas MD Anderson Cancer Center , Bastrop , TX , USA., Saha P; c Division of Diabetes, Endocrinology and Metabolism, Department of Medicine , Baylor College of Medicine , Houston , TX , USA., Kulkarni V; e Department of Virology and Immunology , Texas Biomedical Research Institute , San Antonio , TX , USA., Lakhashe SK; e Department of Virology and Immunology , Texas Biomedical Research Institute , San Antonio , TX , USA., Esquivel J; e Department of Virology and Immunology , Texas Biomedical Research Institute , San Antonio , TX , USA., Nehete PN; d Department of Comparative Medicine , The University of Texas MD Anderson Cancer Center , Bastrop , TX , USA., Ruprecht RM; e Department of Virology and Immunology , Texas Biomedical Research Institute , San Antonio , TX , USA.; f Southwest National Primate Research Center , Texas Biomedical Research Institute , San Antonio , TX , USA.; g Department of Microbiology, Immunology & Molecular Genetics , The University of Texas Health Science Center at San Antonio , San Antonio , TX , USA., Sastry KJ; h Department of Immunology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Meyer JM; i Department of Veterinary Medicine and Surgery , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Hill LR; i Department of Veterinary Medicine and Surgery , The University of Texas MD Anderson Cancer Center , Houston , TX , USA., Lake JE; a Division of Infectious Diseases, Department of Internal Medicine , The University of Texas Health Science Center at Houston , Houston , TX , USA., Balasubramanyam A; c Division of Diabetes, Endocrinology and Metabolism, Department of Medicine , Baylor College of Medicine , Houston , TX , USA., Lewis DE; a Division of Infectious Diseases, Department of Internal Medicine , The University of Texas Health Science Center at Houston , Houston , TX , USA.

Publikováno v: Adipocyte [Adipocyte] 2019 Dec; Vol. 8 (1), pp. 154-163.